With the health care sector brimming with opportunities, some stocks stand out as undervalued diamonds in the rough.
One metric drawing attention is the Relative Strength Index (RSI), a momentum indicator that can help forecast a stock’s short-term performance based on its price history.
When the RSI dips below 30, it signals that a stock may be oversold, presenting a chance for investors to buy low and potentially reap the rewards when prices rebound.
Haemonetics Corporation HAE
- On August 8, Haemonetics exceeded earnings expectations, yet its stock slumped by roughly 19% over the past month, hitting a 52-week low of $70.74.
- RSI Value: 25.47
- HAE Price Action: Haemonetics shares rose 1.1% to close at $73.99 on Thursday.
Immunitybio Inc IBRX
- On August 6, ImmunityBio announced a study on ANKTIVA paired with the AdHER2DC cancer vaccine for endometrial cancer management. Despite this positive news, its stock tumbled by around 38% in the last month, with a 52-week low of $1.25.
- RSI Value: 29.87
- IBRX Price Action: Immunitybio shares climbed 2.6% to end at $3.98 on Thursday.
Progyny Inc PGNY
- On August 6, Progyny reported lower-than-expected second-quarter revenue figures. CEO Pete Anevski noted that second-quarter utilization rates aligned with their projections, indicating stable treatment demand in line with historical trends. Despite this, Progyny’s stock nosedived by approximately 31% in the past month, reaching a 52-week low of $19.60.
- RSI Value: 29.06
- PGNY Price Action: Progyny shares saw a 1.7% increase, closing at $20.85 on Thursday.
These health care stocks offer an alluring proposition for investors looking to capitalize on potential upswings. While recent performances have been lackluster, the RSI values suggest that these companies may be primed for a reversal in fortunes. With strategic investments and an eye on market trends, discerning investors could stand to profit from these underappreciated opportunities.
Read Next:
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
